MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Clinical features"

  • 2017 International Congress

    Axial Myoclonus in a Patient with PSP

    R. Passo, T. Clark (Portland, OR, USA)

    Objective: This is a case report from the Portland VA Medical Center. Background: PSP is a parkinsonian neurodegenerative disorder characterized by deposition of tau in…
  • 2017 International Congress

    Asymmetric Orthostaic Myoclonus – A Case Series

    Y.-c. Tai, J.-c. Tsou, S.-P. Hsu (Kaohsiung City, Taiwan)

    Objective: To present the first case series of asymmetric orthostatic myoclnus and its reversibility along with the improvement of the underlying disease Background: Orthostatic myoclonus…
  • 2017 International Congress

    Reappraisal of Progressive Myoclonus Ataxia

    S. vd Veen, R. Zutt, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: To define the clinical, electrophysiological and etiological features of progressive myoclonus ataxia (PMA). Background: PMA, formerly known as the Ramsay Hunt syndrome, is a…
  • 2017 International Congress

    Clinical and electrophysiological features of seven patients with moving toes syndrome: Is it a type of spinal segmental myoclonus?

    G. Kiziltan, H. Kurucu, C. Yalcinkaya, A. Gunduz, M. E. Kiziltan (Istanbul, Turkey)

    Objective: We aimed to present a case series of moving toes syndrome to show how clinical presentation and electrophysiological findings may change. Background: The moving…
  • 2017 International Congress

    Gait impairment and cognitive changes in a case of thalamic dementia and motor neuron disease.

    S. O'Shea, O. Levy, J.P. Vonsattel, E. Cortes, K. Marder, H. Mitsumoto, R. Alcalay (New York, NY, USA)

    Objective: To describe a case of a 54-year-old woman diagnosed with atypical corticobasal syndrome (CBS). Neuropathological studies revealed that she had thalamic dementia with motor…
  • 2016 International Congress

    Myoclonus complicating chickenpox: A case report

    F. Imounan, N. Daoudi (Meknes, Morocco)

    Objective: To report myoclonus and other movements disorders complicating chickenpox. Background: The meningoencephalitis is a rare complication of chickenpox. The occurrence of movements disorders is…
  • 2016 International Congress

    Alcohol-responsive action myoclonus of the leg in prostate cancer: A novel paraneoplastic syndrome

    P. Termsarasab, S.J. Frucht (New York, NY, USA)

    Objective: To describe two patients with prostate cancer and identical phenotypes of likely paraneoplastic unilateral leg myoclonus. Background: Paraneoplastic movement disorders (PMDs) in prostate cancer…
  • 2016 International Congress

    How do we clinically distinguish subtypes of myoclonus? A retrospective study

    R. Zutt, J.W. Elting, H. van der Hoeven, F. Lange, M.A.J. Tijssen (Groningen, Netherlands)

    Objective: To evaluate the accuracy of clinical phenotyping in a heterogeneous cohort of patients presenting with myoclonus and to determine clinical characteristics. Furthermore, we studied…
  • 2016 International Congress

    Transient myoclonic state in the elderly: A new entity in the classification of myoclonus

    T. Hashimoto, T. Doden, H. Sato (Matsumoto, Japan)

    Objective: To clarify the clinical picture of transient myoclonic state in elderly patients and to establish a position in the classification of myoclonus. Background: Transient…
  • 2016 International Congress

    Topiramate responsive adult-onset opsoclonus myoclonus ataxia syndrome

    Y. Degirmenci, H. Kececi (Duzce, Turkey)

    Objective: Opsoclonus myoclonus ataxia (OMA) is a rare neurological syndrome characterized with with autoimmune background. However the exact pathophysiology is not clear. Most common underlying…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley